[Frontiers in Bioscience, Landmark, 25, 498-512, Jan 1, 2020]

T-96 attenuates inflammation by inhibiting NF-κB in adjuvant-induced arthritis

Yun Yu1, Bian Yong2, Changliang Xu2, Luyong Zhang1,3,4,5

1Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China, 2Laboratory Animal Center of Nanjing University of Chinese Medicine, Nanjing 210023, China, 3Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, China, 4Key Laboratory of Drug Quality Control and Pharmacovigilance, China Pharmaceutical University, Ministry of Education, Nanjing 210009, China, 5Center for Drug Screening and Pharmacodynamics Evaluation, School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China


1. Abstract
2. Introduction
3. Materials and methods
    3.1. Chemicals and reagents
    3.2. Isolation and culture of fibroblast-like synoviocytes
    3.3. Cell viability assay
    3.4. ELISA
    3.5. Nitric oxide (NO) measurement
    3.6. Western blotting
    3.7. Arthritic rats
    3.8. Experimental procedure
    3.9. Histopathological examination
    3.10. Immunohistochemical assessment
    3.11. Statistical analysis
4. Results
    4.1. Evaluation of cytotoxicity in normal FLSs
    4.2. T-96 attenuates IL-1β-induced inflammatory signaling
    4.3. T-96 attenuates IL-1β-induced target protein expression and NO production
    4.4. T-96 decreases paw swelling, arthritis indices, and weight loss in arthritic rats
    4.5. Effects of T-96 on histopathological changes in arthritic rats
    4.6. Effects of T-96 on the expression of IL-10 and IL-17 in joint synovium in arthritic rats
    4.7. Effects of T-96 on serum levels of cytokines in arthritic rats
5. Discussion
6. Acknowledgments
7. References


The extract of the medicinal plant, Tripterygium wilfordii Hook. f. (TW), has been used in the treatment of diverse autoimmune diseases, including rheumatoid arthritis. However, the high frequency of toxic side effects has limited its clinical use. In order to reduce toxicity without losing the therapeutic benefit, the pharmacological activity and toxicity of four compounds (T-96, triptolide, neotripterifordin, and tripterifordin) from TW were evaluated. The current study revealed that these compounds interfere with the IL-1β signaling pathway, which stimulates the secretion of pro-inflammatory cytokines (IL-6) in primary rheumatoid arthritis synovial fibroblasts (RASFs). These compounds inhibit IL-6 production, and among these, T-96 was the most effective. Moreover, T-96 blocks activation of NF-kappa B and p38 and ameliorates the joint destruction and the clinical signs of the disease in adjuvant-induced arthritic rats. These data suggest that among the four compounds of the TW, T-96 possesses highest anti-rheumatoid arthritis activity though inhibiting IL-1-mediated inflammatory signaling pathways.


1. B. Bartok and G. S. Firestein: Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev, 233(1), 233-55 (2010)
DOI: 10.1111/j.0105-2896.2009.00859.x

2. S. E. Gabriel and K. Michaud: Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther, 11(3), 229 (2009)
DOI: 10.1186/ar2669

3. S. K. Lundy, S. Sarkar, L. A. Tesmer and D. A. Fox: Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther, 9(1), 202 (2007)
DOI: 10.1186/ar2107

4. S. Bugatti, B. Vitolo, R. Caporali, C. Montecucco and A. Manzo: B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. Biomed Res Int, 2014, 681678 (2014)
DOI: 10.1155/2014/681678

5. R. W. Kinne, B. Stuhlmuller and G. R. Burmester: Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther, 9(6), 224 (2007)
DOI: 10.1186/ar2333

6. V. S. Honmore, A. D. Kandhare, P. P. Kadam, V. M. Khedkar, A. D. Natu, S. R. Rojatkar and S. L. Bodhankar: Diarylheptanoid, a constituent isolated from methanol extract of Alpinia officinarum attenuates TNF-alpha level in Freund's complete adjuvant-induced arthritis in rats. J Ethnopharmacol, 229, 233-245 (2019)
DOI: 10.1016/j.jep.2018.10.019

7. L. D. Quan, G. M. Thiele, J. Tian and D. Wang: The Development of Novel Therapies for Rheumatoid Arthritis. Expert Opin Ther Pat, 18(7), 723-738 (2008)
DOI: 10.1517/13543776.

8. N. Mu, J. Gu, T. Huang, C. Zhang, Z. Shu, M. Li, Q. Hao, W. Li, W. Zhang, J. Zhao, Y. Zhang, L. Huang, S. Wang, X. Jin, X. Xue, W. Zhang and Y. Zhang: A novel NF-kappaB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis. Sci Rep, 6, 20059 (2016)
DOI: 10.1038/srep20059

9. M. F. Bustamante, R. Garcia-Carbonell, K. D. Whisenant and M. Guma: Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther, 19(1), 110 (2017)
DOI: 10.1186/s13075-017-1303-3

10. S. M. Jung, K. W. Kim, C. W. Yang, S. H. Park and J. H. Ju: Cytokine-mediated bone destruction in rheumatoid arthritis. J Immunol Res, 2014, 263625 (2014)
DOI: 10.1155/2014/263625

11. N. Latruffe: Natural Products and Inflammation. Molecules, 22(1) (2017)
DOI: 10.3390/molecules22010120

12. A. Lancon, R. Frazzi and N. Latruffe: Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases. Molecules, 21(3), 304 (2016)
DOI: 10.3390/molecules21030304

13. A. R. Setty and L. H. Sigal: Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum, 34(6), 773-84 (2005)
DOI: 10.1016/j.semarthrit.2005.01.011

14. K. Maekawa, N. Yoshikawa, J. Du, S. Nishida, H. Kitasato, K. Okamoto, H. Tanaka, Y. Mizushima and S. Kawai: The molecular mechanism of inhibition of interleukin-1beta-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract. Inflamm Res, 48(11), 575-81 (1999)
DOI: 10.1007/s000110050506

15. X. Tao, H. Schulze-Koops, L. Ma, J. Cai, Y. Mao and P. E. Lipsky: Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum, 41(1), 130-8 (1998)

16. S. Xu, H. Bayat, X. Hou and B. Jiang: Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-kappaB through phosphorylation of IkappaBbeta. Am J Physiol Cell Physiol, 291(6), C1336-45 (2006)
DOI: 10.1152/ajpcell.00552.2005

17. Y. J. Choi, W. S. Lee, E. G. Lee, M. S. Sung and W. H. Yoo: Sulforaphane inhibits IL-1beta-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of MMPs, COX-2, and PGE2. Inflammation, 37(5), 1496-503 (2014)
DOI: 10.1007/s10753-014-9875-4

18. H. M. Doss, R. Ganesan and M. Rasool: Trikatu, an herbal compound ameliorates rheumatoid arthritis by the suppression of inflammatory immune responses in rats with adjuvant-induced arthritis and on cultured fibroblast like synoviocytes via the inhibition of the NFkappaB signaling pathway. Chem Biol Interact, 258, 175-86 (2016)

19. D. M. Pereira, G. Correia-da-Silva, P. Valentao, N. Teixeira and P. B. Andrade: Palmitic acid and ergosta-7,22-dien-3-ol contribute to the apoptotic effect and cell cycle arrest of an extract from Marthasterias glacialis L. in neuroblastoma cells. Mar Drugs, 12(1), 54-68 (2013)
DOI: 10.3390/md12010054

20. T. Y. Forbes-Hernandez, F. Giampieri, M. Gasparrini, S. Afrin, L. Mazzoni, M. D. Cordero, B. Mezzetti, J. L. Quiles and M. Battino: Lipid Accumulation in HepG2 Cells Is Attenuated by Strawberry Extract through AMPK Activation. Nutrients, 9(6) (2017)
DOI: 10.3390/nu9060621

21. C. Chen, C. Zhang, L. Cai, H. Xie, W. Hu, T. Wang, D. Lu and H. Chen: Baicalin suppresses IL-1beta-induced expression of inflammatory cytokines via blocking NF-kappaB in human osteoarthritis chondrocytes and shows protective effect in mice osteoarthritis models. Int Immunopharmacol, 52, 218-226 (2017)
DOI: 10.1016/j.intimp.2017.09.017

22. S. Li, J. W. Chen, X. Xie, J. Tian, C. Deng, J. Wang, H. N. Gan and F. Li: Autophagy inhibitor regulates apoptosis and proliferation of synovial fibroblasts through the inhibition of PI3K/AKT pathway in collagen-induced arthritis rat model. Am J Transl Res, 9(5), 2065-2076 (2017)

23. H. Liu, P. Eksarko, V. Temkin, G. K. Haines, 3rd, H. Perlman, A. E. Koch, B. Thimmapaya and R. M. Pope: Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis. J Immunol, 175(12), 8337-45 (2005)

24. Q. Q. Huang, R. Sobkoviak, A. R. Jockheck-Clark, B. Shi, A. M. Mandelin, 2nd, P. P. Tak, G. K. Haines, 3rd, C. V. Nicchitta and R. M. Pope: Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol, 182(8), 4965-73 (2009)
DOI: 10.4049/jimmunol.0801563

25. C. C. Scholz, M. A. Cavadas, M. M. Tambuwala, E. Hams, J. Rodriguez, A. von Kriegsheim, P. Cotter, U. Bruning, P. G. Fallon, A. Cheong, E. P. Cummins and C. T. Taylor: Regulation of IL-1beta-induced NF-kappaB by hydroxylases links key hypoxic and inflammatory signaling pathways. Proc Natl Acad Sci U S A, 110(46), 18490-5 (2013)
DOI: 10.1073/pnas.1309718110

26. P. P. Tak and G. S. Firestein: NF-kappaB: a key role in inflammatory diseases. J Clin Invest, 107(1), 7-11 (2001)
DOI: 10.1172/JCI11830

27. W. P. Chen, Z. G. Yang, P. F. Hu, J. P. Bao and L. D. Wu: Acacetin inhibits expression of matrix metalloproteinases via a MAPK-dependent mechanism in fibroblast-like synoviocytes. J Cell Mol Med, 19(8), 1910-5 (2015)
DOI: 10.1111/jcmm.12564

28. G. S. Firestein and I. B. McInnes: Immunopathogenesis of Rheumatoid Arthritis. Immunity, 46(2), 183-196 (2017)
DOI: 10.1016/j.immuni.2017.02.006

29. A. J. van Zonneveld, H. C. de Boer, E. P. van der Veer and T. J. Rabelink: Inflammation, vascular injury and repair in rheumatoid arthritis. Ann Rheum Dis, 69 Suppl 1, i57-60 (2010)
DOI: 10.1136/ard.2009.119495

30. X. Tao, J. Younger, F. Z. Fan, B. Wang and P. E. Lipsky: Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis Rheum, 46(7), 1735-43 (2002)
DOI: 10.1002/art.10411

31. X. Tao, J. J. Cush, M. Garret and P. E. Lipsky: A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol, 28(10), 2160-7 (2001)

32. Q. W. Lv, W. Zhang, Q. Shi, W. J. Zheng, X. Li, H. Chen, Q. J. Wu, W. L. Jiang, H. B. Li, L. Gong, W. Wei, H. Liu, A. J. Liu, H. T. Jin, J. X. Wang, X. M. Liu, Z. B. Li, B. Liu, M. Shen, Q. Wang, X. N. Wu, D. Liang, Y. F. Yin, Y. Y. Fei, J. M. Su, L. D. Zhao, Y. Jiang, J. Li, F. L. Tang, F. C. Zhang, P. E. Lipsky and X. Zhang: Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis, 74(6), 1078-86 (2015)

33. J. Sylvester, A. Liacini, W. Q. Li, F. Dehnade and M. Zafarullah: Tripterygium wilfordii Hook F extract suppresses proinflammatory cytokine-induced expression of matrix metalloproteinase genes in articular chondrocytes by inhibiting activating protein-1 and nuclear factor-kappaB activities. Mol Pharmacol, 59(5), 1196-205 (2001)

34. Y. Li, J. Wang, Y. Xiao, Y. Wang, S. Chen, Y. Yang, A. Lu and S. Zhang: A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis. J Ethnopharmacol, 175, 301-14 (2015)

35. J. L. Funk, L. A. Cordaro, H. Wei, J. B. Benjamin and D. E. Yocum: Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis. J Clin Invest, 101(7), 1362-71 (1998)

36. B. F. Cheng, Y. X. Gao, J. J. Lian, D. D. Guo, L. Wang, M. Wang, H. J. Yang and Z. W. Feng: Hydroxysafflor yellow A inhibits IL-1beta-induced release of IL-6, IL-8, and MMP-1 via suppression of ERK, NF-kappaB and AP-1 signaling in SW982 human synovial cells. Food Funct, 7(11), 4516-4522 (2016)
DOI: 10.1039/c6fo01045h

37. D. Burger, J. M. Dayer, G. Palmer and C. Gabay: Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol, 20(5), 879-96 (2006)

38. A. J. Whitmarsh, S. H. Yang, M. S. Su, A. D. Sharrocks and R. J. Davis: Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol, 17(5), 2360-71 (1997)

39. M. Suzuki, T. Tetsuka, S. Yoshida, N. Watanabe, M. Kobayashi, N. Matsui and T. Okamoto: The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett, 465(1), 23-7 (2000)

40. C. Georganas, H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya and R. M. Pope: Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun. J Immunol, 165(12), 7199-206 (2000)

Key Words: T-96, NF-kappaB, Rheumatoid Arthritis, Fibroblast-like synoviocytes

Send correspondence to: Luyong Zhang, Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing 210009, China. E-mail: lyzhang@cpu.edu.cn; Changliang Xu, PhD. Laboratory Animal Center of Nanjing University of Chinese Medicine, Nanjing 210023, China, Tel: 025-85811256, Fax: 025-83271142, E-mail: cl.xu81@gmail.com